United States Nuclear Regulatory Commission - Protecting People and the Environment
Home > About NRC > How We Regulate > Advisory Activities > Advisory Committee on the Medical Uses of Isotopes > ACMUI Novoste Analysis

ACMUI Novoste Analysis

The following documents provide an analysis of the root cause of medical events that involve Novoste Beta Cath intravascular brachytherapy system. The Nuclear Regulatory Commission's Advisory Committee on the Medical Uses of Isotopes (ACMUI) performed this analysis. Members of the ACMUI who participated in the analysis will present their findings at the November 12-13, 2003, ACMUI public meeting.

All conclusions are preliminary. Conclusions may be adjusted based upon future information.

This page includes links to files in non-HTML format. See Plugins, Viewers, and Other Tools for more information.

 

Page Last Reviewed/Updated Thursday, March 29, 2012